Excimer Light Versus Blue Light in Acne

N/ANot Yet RecruitingNCT06725303

Cairo University24 enrolled

Overview

The aim is to assess the efficacy and safety of Excimer Light versus blue light in the treatment of inflammatory acne.

The use of new light energy in inflammatory acne

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Acne Vulgaris

Interventions

ExcimerDEVICE

Light energy

Eligibility

Sex: ALLMin age: 18 YearsMax age: 25 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with mild to moderate inflammatory acne lesions Exclusion Criteria: * Pregnancy during the first trimester * Female patients with a medical history of PCO * Topical and systemic treatment within the last month and systemic retinoids for 6 months * Patients on systemic steroid treatment or hormonal therapy * Severe systemic illness or malignancy * Photosensitivity * Scarring acne vulgaris

Outcomes

Primary Outcomes

Number of comedones, papules and pustules

number of lesions

Time frame: 2 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.